Wavely Diagnostics
Wavely Diagnostics is a Seattle-based digital diagnostics company selling WavelyDx, an FDA-listed smartphone app that uses acoustic reflectometry and AI to detect middle-ear fluid in children, serving parents, pediatric practices, and telehealth partners.
- Company typePrivate
- Founded2019
- HeadquartersSeattle, United States
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What Wavely Diagnostics does
Wavely Diagnostics is a Seattle-based digital diagnostics company that has built WavelyDx®, an FDA-listed Class II Exempt smartphone application that uses acoustic reflectometry and a proprietary machine-learning classifier to detect middle-ear fluid in children. Founded in 2019 as a spin-out from the University of Washington and Seattle Children's Hospital, the company converts a consumer iPhone (and, as of 2026, Android) into a screening tool by emitting a calibrated 80 dB SPL chirp through a disposable silicone ear tip and analyzing the reflected acoustic signature from the tympanic membrane, returning a "Likely" or "Unlikely" middle-ear-fluid result in roughly 30 seconds (reported 84.5% accuracy vs. tympanocentesis and 97% first-scan success). The product is positioned as a more accessible alternative to in-clinic otoscopy for parents deciding whether a sick child needs to be seen, and as a remote diagnostic input for pediatric and telehealth providers.
WavelyDx sells through a hybrid razor/blade-plus-subscription model: recurring ear tip consumables ($9.99 per 6-pack, $17 starter kit), app subscriptions ($27 per 3 months, $39–$60 per year for the Family Protect plan, $9 per week pay-as-you-go), and B2B/clinical-channel revenue from pediatric practices and telehealth partners. Distribution spans the company's own storefront, the Apple App Store (and Google Play as of 2026), Amazon for ear tip consumables, and integrations with telehealth platforms Azova, Summer Health, and Apertur, plus clinical-study relationships with pediatric practices such as Puffin Pediatrics and Senders Pediatrics and accelerator affiliations with KidsX and Springboard.
The company has raised approximately $6.35M in cumulative disclosed equity funding across a $2.2M seed in February 2022 (led by Ambit Health Ventures) and a $1.35M seed in July 2023 (led by Robin Hood Ventures), supplemented by non-dilutive NIH SBIR (~$1.8M via NIMHD) and CTIP Health Equity FlexGrant capital. It remains privately held with a founder/CEO-led team of 11–50 employees, US-only and iOS-only at commercial launch, and an FDA-listed Class II Exempt regulatory posture supporting direct-to-consumer distribution.
Wavely Diagnostics firmographics
Firmographics- Name
- Wavely Diagnostics
- Legal name
- Wavely Diagnostics, Inc.
- Website
- https://wavelydx.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Wavely Diagnostics is a Seattle-based digital diagnostics company selling WavelyDx, an FDA-listed smartphone app that uses acoustic reflectometry and AI to detect middle-ear fluid in children, serving parents, pediatric practices, and telehealth partners.
- Ownership category
- akta.pro rank
Wavely Diagnostics industry classification
Industry- Product category
- Pediatric Digital Health Diagnostics
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Home Diagnostic & Self-Test OTC Kits (HLAIADAO)
Keywords
Where Wavely Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Seattle
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Wavely Diagnostics business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others
Revenue model
- App subscription (recurring): Recurring access to the WavelyDx iOS app and AI-powered ear scan results, sold as monthly/3-month/annual plans (e.g., $27/3-month, $60/year annual Family Protect, pay-as-you-go $9/week). Subscription is the primary recurring software stream.
- Consumable ear tip hardware sales: Recurring and one-time sales of disposable silicone ear tips required to use the app (e.g., $9.99 per 6-pack, $17 starter kit, free 2-tip sample pack). Functions as a razor/blade-style consumable tied to active app use.
- Provider and clinical channel revenue: Sales of ear tip kits and access to pediatric and telehealth practices (e.g., Puffin Pediatrics, Senders Pediatrics) and integration partners (Azova, Summer Health, Auggie/KidsX ecosystem).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free sample pack of 2 ear tips |
| One time/ perpetual license | Pay-as-you-go | Starter kit at $17 |
| Unit Pricing | Pay-as-you-go | 6-pack of ear tips at $9.99 |
| Subscription | Monthly | 3-month app subscription at $27 ($9/month) |
| Subscription | Annual | Annual Family Protect plan at $60 ($5/month) |
| Subscription | Annual | Annual Family Protect plan at $39/year (alternate positioning) |
| Usage-based | Pay-as-you-go | Pay-as-you-go at $9/week |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels8 records
Wavely Diagnostics product offering
Product offeringCore offering
Wavely Diagnostics sells the WavelyDx® Middle Ear Fluid Scanner, a smartphone app (iOS and Android) that uses acoustic reflectometry to detect middle-ear fluid in children at home, paired with a recurring disposable silicone ear-tip consumable. The platform is FDA-listed as a Class II Exempt medical device, reports ~84.5% accuracy and 97% first-scan success in roughly 30 seconds, and is sold both direct-to-consumer (app subscriptions, ear-tip kits) and through pediatric practices and telehealth partners (Azova, Summer Health, Apertur) with a clinician portal for provider use.
Product overview
Wavely Diagnostics sells a single unified consumer product — the WavelyDx® Middle Ear Fluid Scanner — built around a smartphone app that uses acoustic reflectometry to detect middle-ear fluid in children. The offering is platform-plus-modules in practice: the WavelyDx iOS app (and the recently released Android app) is the core, paired with the WavelyDx Ear Tips disposable accessory. On top of that core, the company layers (a) the WavelyDx for Providers clinician portal for telehealth practices, (b) bundled integrations with telehealth partners Summer Health and AZOVA that escalate positive scans to virtual consults, (c) inclusion in the Apertur "Virtual Medicine Cabinet" unified subscription, and (d) subscription tiers (3-month, annual Family Protect plan, and pay-as-you-go weekly) for the consumer app.
Differentiator
Problem solved
Functional benefit
Brands
- WavelyDx®: Consumer-facing brand used for Wavely's FDA-listed smartphone middle ear fluid scanner system, including the iOS/Android app and disposable ear tip accessories.
Products and services
- WavelyDx App (iOS) Smartphone application that plays a soft chirp into the ear canal via the attached ear tip, records the acoustic reflection from the eardrum, and uses a proprietary machine-learning model to return a Likely or Unlikely middle-ear-fluid result for at-home pediatric ear-infection triage. Sold on the Apple App Store and required to run scans and access subscription tiers.
- WavelyDx Ear Tips Single-use disposable silicone ear tips (sold in 6-packs for $9.99 and in starter kits) that attach to the iPhone in seconds and direct the soft chirp into the ear canal toward the eardrum. Required consumable for every WavelyDx scan session and the hardware anchor of the company's razor/blade recurring-revenue model.
- WavelyDx for Providers Clinician portal that lets pediatric and telehealth practices distribute Access Codes to families, capture clinical scan reports from WavelyDx scans, and use the middle-ear-fluid finding to support remote diagnosis, antibiotic stewardship, and shorter virtual visits for suspected ear infections.
- WavelyDx Android App Android version of the WavelyDx smartphone ear-infection scanner app, released on Google Play and currently limited to specific supported phone models. Extends the company's smartphone-native diagnostic platform beyond iOS.
- WavelyDx + Summer Health tele-peds integration Bundled offering in which a positive WavelyDx scan unlocks an instant Summer Health tele-pediatric visit; the Summer Health provider already receives the scan data and can call in prescriptions within minutes.
- WavelyDx + Apertur Virtual Medicine Cabinet Unified-app offering (announced July 22, 2025) that places WavelyDx's at-home ear-infection detection alongside Apertur's concussion screening under a single subscription and unified user experience for parents.
Quantifiable outcome
- 84.5% reported diagnostic accuracy for ear infection detection
- +3 more outcomes
Companies that use Wavely Diagnostics
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Wavely Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability3 records
Feature6 records
Wavely Diagnostics partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- AperturcoreStrategic collaboration with WavelyDx on the Unified Virtual Medicine Cabinet initiative, integrating WavelyDx's at-home ear infection screening into a broader virtual care ecosystem.
- Summer HealthcoreTele-peds partner collaborating with WavelyDx on an ear infection care pathway that combines Summer Health's virtual pediatric visits with WavelyDx's at-home smartphone ear scan.
- AzovacoreVirtual doctor / telehealth partner that integrates WavelyDx into Azova's consults, enabling remote ear infection triage via at-home smartphone scans.
- University of WashingtoncoreWavely Diagnostics originated from research at the University of Washington, which serves as the academic/research foundation for the company's smartphone acoustic reflectometry technology.
- Seattle Children's HospitalcoreCo-origin partner with the University of Washington for Wavely Diagnostics, providing pediatric clinical research and validation foundation.
- KidsXminorPediatric digital health accelerator ecosystem in which Wavely Diagnostics participates, providing ecosystem access, mentorship, and hospital channel introductions.
- SpringboardminorAccelerator/ecosystem partner supporting Wavely Diagnostics' growth, with a focus on women-led technology companies.
- Puffin PediatricsminorPediatric practice participating as a clinical study partner with Wavely Diagnostics, with Dr. Matt Fradkin as a named collaborator on ear infection screening workflows.
- Senders PediatricsminorPediatric practice referenced as a clinical partner in Wavely Diagnostics' clinical study and provider-distribution activity.
Scale indicators14 records
Recent moves7 records
Expansion highlights6 records
Wavely Diagnostics competitors and assessment
Company assessmentDirect peers
- Oto (formerly CellScope): Oto is the closest direct competitor: a smartphone-based otoscope / ear-health product aimed at parents and consumers to screen for ear infections at home. It targets the same pediatric ear-infection use case with a similar DTC model, making it the most directly comparable peer to WavelyDx.
- TytoCare: TytoCare sells a handheld at-home medical exam device paired with telehealth visits, including an otoscope attachment for ear-infection screening. It competes with WavelyDx in the at-home pediatric ear assessment and telehealth triage pathway, though using dedicated hardware rather than a smartphone-only solution.
- Healthy.io: Healthy.io is a smartphone-based home diagnostics company (UTI testing, kidney disease screening) that pairs a phone camera/sensor workflow with a consumable kit and AI interpretation. Its smartphone-native diagnostic, consumable-driven model, and FDA-listed positioning closely mirror WavelyDx's go-to-market and regulatory pattern.
Emerging players
- Eko Health: Eko Health builds AI-powered digital stethoscopes and cardiac/pulmonary diagnostic devices, with FDA-cleared products used by clinicians and increasingly in remote monitoring. It is comparable as a digital auscultation/diagnostics peer building a hardware-plus-AI model for clinical decision support, though its core use cases are cardiac and pulmonary rather than ear.
- Blueberry Pediatrics: Blueberry Pediatrics is a subscription-based pediatric telehealth and house-call service for families with young children, including ear-infection consultations. It overlaps with WavelyDx in the pediatric ear-infection care pathway and is a natural partner / competitor for the same parent segment.
- Hazel Health: Hazel Health provides pediatric telehealth services, including into schools, covering common childhood conditions such as ear infections. It is comparable to WavelyDx in targeting the pediatric virtual care channel and is a potential B2B channel partner for school- and parent-facing ear-infection screening.
- Remmie Health: Remmie Health makes a smartphone-enabled otoscope/ENT device for at-home ear, nose, and throat visualization and remote provider review. It is a direct adjacent competitor in smartphone-native ENT diagnostics, sharing the same parent/caregiver target user and the at-home ear-exam use case as WavelyDx.
Broad incumbents
- Ro (Roman Health): Ro is a large direct-to-consumer telehealth and digital health platform covering multiple conditions with subscription-based care and pharmacy delivery. It is comparable to WavelyDx in the DTC consumer health model, although it operates at a much broader condition and category scale.
- Hims & Hers Health: Hims & Hers is a major DTC consumer health brand operating across telehealth, prescription, and wellness categories with a strong subscription and consumer-brand model. It is broadly comparable to WavelyDx's DTC consumer-health positioning, but at vastly greater scale and category breadth.
- K Health: K Health is an AI-driven direct-to-consumer primary care and telehealth platform that combines chat-based triage with clinician visits and subscription plans. It is comparable to WavelyDx in the DTC virtual-care and AI-augmented triage model, though K Health is condition-agnostic and operates at significantly larger scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Wavely Diagnostics social profiles
Digital presenceWavely Diagnostics compliance and trust
Trust signalCompliance3 records
Wavely Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wavely Diagnostics leadership team
Management profileNumber of profiles
Profiles12 records
Wavely Diagnostics funding detail
Funding detailFunding overview
Funding rounds9 records
Investors16 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wavely Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wavely Diagnostics
What does Wavely Diagnostics do?
Wavely Diagnostics sells the WavelyDx® Middle Ear Fluid Scanner, a smartphone app (iOS and Android) that uses acoustic reflectometry to detect middle-ear fluid in children at home, paired with a recurring disposable silicone ear-tip consumable. The platform is FDA-listed as a Class II Exempt medical device, reports ~84.5% accuracy and 97% first-scan success in roughly 30 seconds, and is sold both direct-to-consumer (app subscriptions, ear-tip kits) and through pediatric practices and telehealth partners (Azova, Summer Health, Apertur) with a clinician portal for provider use.
Is Wavely Diagnostics a public or private company?
Wavely Diagnostics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Wavely Diagnostics founded?
Wavely Diagnostics was founded in 2019. It employs 11 to 50 people.
Where is Wavely Diagnostics based?
Wavely Diagnostics is headquartered in Seattle, United States, in the North America region.
How does Wavely Diagnostics make money?
Three revenue lines are on record. App subscription (recurring) is the primary driver. The others are consumable ear tip hardware sales and provider and clinical channel revenue.
Who are Wavely Diagnostics's main competitors?
Direct peers on record are Oto (formerly CellScope), TytoCare and Healthy.io. Emerging players are Eko Health, Blueberry Pediatrics, Hazel Health and Remmie Health. Broad incumbents are Ro (Roman Health), Hims & Hers Health and K Health.
Does Wavely Diagnostics have an API?
No public API is recorded for Wavely Diagnostics.
What industry is Wavely Diagnostics in?
Wavely Diagnostics's product category is Pediatric Digital Health Diagnostics. Its primary akta.pro industry code is HLAIADAO, Home Diagnostic & Self-Test OTC Kits. Its NAICS code is 334510 and its SIC code is 3841.